Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Breunig

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Drug Discovery Today|March 26, 2019
Causative glaucoma treatment: promising targets and delivery systemsRaphael Mietzner, Miriam Breunig
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 22, 2020
Considerations for efficient surface functionalization of nanoparticles with a high molecular weight protein as targeting ligandStefanie Thalhauser, Miriam Breunig
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 4, 2016
Hyaluronan as a promising excipient for ocular drug deliveryMichaela Guter, Miriam Breunig
Methods in Molecular Biology (Clifton, N.J.)|March 7, 2019
Layer-by-Layer Assembled Nanoparticles for siRNA DeliveryMichaela Guter, Miriam Breunig
Advanced Healthcare Materials|November 10, 2017
Preventing Obstructions of Nanosized Drug Delivery Systems by the Extracellular MatrixLuise Tomasetti, Miriam Breunig
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
Monitoring the degradation of reduction-sensitive gene carriers with fluorescence spectroscopy and flow cytometryConstantin Hozsa, Miriam Breunig, Achim Göpferich
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 1, 2021
Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology - A new chance for causative therapy?Jonas Groner, Achim Goepferich, Miriam Breunig
Medizinische Genetik : Mitteilungsblatt Des Berufsverbandes Medizinische Genetik E.V|February 13, 2025
Nanoparticles in intraocular drug deliveryStefanie E Klaus, Miriam Breunig, Achim Göpferich
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 2, 2019
Critical design criteria for engineering a nanoparticulate HIV-1 vaccineStefanie Thalhauser, David Peterhoff, Ralf Wagner, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Breaking up the correlation between efficacy and toxicity for nonviral gene deliveryMiriam Breunig, Uta Lungwitz, Renate Liebl, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Drug Discovery Today|March 26, 2019
Causative glaucoma treatment: promising targets and delivery systemsRaphael Mietzner, Miriam Breunig
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 22, 2020
Considerations for efficient surface functionalization of nanoparticles with a high molecular weight protein as targeting ligandStefanie Thalhauser, Miriam Breunig
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 4, 2016
Hyaluronan as a promising excipient for ocular drug deliveryMichaela Guter, Miriam Breunig
Methods in Molecular Biology (Clifton, N.J.)|March 7, 2019
Layer-by-Layer Assembled Nanoparticles for siRNA DeliveryMichaela Guter, Miriam Breunig
Advanced Healthcare Materials|November 10, 2017
Preventing Obstructions of Nanosized Drug Delivery Systems by the Extracellular MatrixLuise Tomasetti, Miriam Breunig
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
Monitoring the degradation of reduction-sensitive gene carriers with fluorescence spectroscopy and flow cytometryConstantin Hozsa, Miriam Breunig, Achim Göpferich
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 1, 2021
Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology - A new chance for causative therapy?Jonas Groner, Achim Goepferich, Miriam Breunig
Medizinische Genetik : Mitteilungsblatt Des Berufsverbandes Medizinische Genetik E.V|February 13, 2025
Nanoparticles in intraocular drug deliveryStefanie E Klaus, Miriam Breunig, Achim Göpferich
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 2, 2019
Critical design criteria for engineering a nanoparticulate HIV-1 vaccineStefanie Thalhauser, David Peterhoff, Ralf Wagner, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Breaking up the correlation between efficacy and toxicity for nonviral gene deliveryMiriam Breunig, Uta Lungwitz, Renate Liebl, et al.
Pageof 5